Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 231-240 of 410 for

  • Results filtered:
  • Study status: Open/Status Unknown
Edit search filters
  1. Exploring the Role of B-cell Activating Factor Receptor (BAFFR)-based Chimeric Antigen Receptor T-cell (CAR T) in BAFFR-expressing B-cell Hematologic Malignancies and Autoimmune Rheumatologic Disorders

    Jacksonville, FL

  2. Cutaneous Lymphoma Database

    Scottsdale/Phoenix, AZ

  3. A Study to Compare Optimal MRI Timing for Pre-surgical Planning to LINAC-based Therapy

    Rochester, MN

  4. Understanding the Relationship Between Benign Breast Tissue, Benign Breast Disease, and Breast Cancer Development

    Jacksonville, FL

  5. ACT-MBC: A Study of Circulating Tumor Cells (CTCs) in Metastatic Breast Cancer (MBC) (ACT-MBC)

    Eau Claire, WI, Mankato, MN, Rochester, MN, Albert Lea, MN

  6. A Study to Evaluate Circulating Cell Free Tumor DNA as a Biomarker in Sarcoma

    Rochester, MN

  7. A Study to Evaluate Contouring Organs at Risk for Treatment Planning

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  8. SULF1 and SULF2 Role in Cholangiocarcinoma

    Rochester, MN

  9. Biorepository for Acute Leukemia Research

    Rochester, MN

  10. A Study to Evaluate the Use of Organoids to Advance Precision Medicine in Bladder Cancer

    Rochester, MN

.

Mayo Clinic Footer